catechin has been researched along with transforming growth factor beta in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (50.00) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 4 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Tang, J; Xu, J; Zhang, L | 1 |
| Kamimura, A; Takahashi, T | 1 |
| Kikuchi, M; Kuboki, Y; Sato, Y; Takita, H | 1 |
| Gershwin, ME; Keen, CL; Mao, TK; Schmitz, HH; Van De Water, J | 1 |
| Hitsuda, Y; Igishi, T; Kodani, M; Matsumoto, S; Nakanishi, H; Shigeoka, Y; Shimizu, E; Yasuda, K | 1 |
| Bollag, WB; Borke, J; Foster, E; Hsu, S; Lapp, C; Lapp, D; Lewis, J; Nah-Do, N; Osaki, T; Rao, S; Schuster, G; Singh, B; Takaaki, K; Walsh, DS; Wataha, J; Yamamoto, T | 1 |
| Deguchi, A; Hara, Y; Moriwaki, H; Shimizu, M; Weinstein, IB | 1 |
| Asaumi, H; Nagashio, Y; Nakamura, H; Nomiyama, Y; Otsuki, M; Taguchi, M; Tashiro, M; Watanabe, S | 1 |
| Chen, A; Yumei, F; Zheng, S; Zhou, Y | 1 |
| Kamimura, A; Morohashi, M; Takahashi, T; Takano, Y | 1 |
| Kim, M; Oya, T; Yamabe, N; Yokozawa, T | 1 |
| Hanai, Y; Hayashi, K; Kato, K; Kozawa, O; Matsushima-Nishiwaki, R; Takai, S; Tokuda, H | 1 |
| Chopra, K; Kuhad, A; Sachdeva, AK; Tiwari, V | 1 |
| Bartrons, R; Bitencourt, S; Bragança de Moraes, CM; dos Santos de Oliveira, F; Melo, DA; Mesquita, FC; Rodrigues de Oliveira, J; Rodriguez-Carballo, E; Rosa, JL; Santos, RC; Ventura, FP | 1 |
| Hsu, SR; Kao, JY; Liu, LC; Tsai, TC; Tsao, TC; Wang, HC; Way, TD | 1 |
| Kim, JH; Kim, ST; Moon, HS; Oh, SH; Park, YB; Seo, JY; Shin, YS | 1 |
| Hayakawa, Y; Kaneto, N; Kato, S; Kin, R; Li, F; Saiki, I; Sakurai, H; Tanaka, K; Yokoyama, S | 1 |
| Bigelow, RL; Cardelli, JA; Coleman, DT; Gray, AL; Stephens, CA | 1 |
| Chen, Y; Deng, Y; Ding, Y; Qian, K; Sun, X | 1 |
| Christiansen, G; Otzen, DE; Stenvang, M | 1 |
| Chakrapani, LN; Johnson, T; Mohan, T; Periandavan, K; Singh, A; Srinivasan, AK; Velusamy, P | 1 |
| Ho, CT; Li, S; Wang, L; Yang, G; Yang, Y; Yuan, L; Zhao, H | 1 |
| Kalirajan, C; Palanisamy, T | 1 |
| Huang, YW; Pang, QQ; Sheng, J; Wang, XJ; Yang, XY; Yu, CJ; Zhang, XJ; Zhu, QQ | 1 |
| Abazari, O; Abbasi, M; Behmard, V; Khanicheragh, P; Maleki, N; Malekpour, M; Nayerpour Dizaj, T; Nejadbiglari, H; Panji, M; Safaeian, A; Shabanzadeh, M; Yavari, S; Zare, Z | 1 |
| Chandraprabha, MN; Monika, P; Murthy, KNC | 1 |
26 other study(ies) available for catechin and transforming growth factor beta
| Article | Year |
|---|---|
The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression.
Topics: Alcohols; Animals; Antioxidants; Apoptosis; Blotting, Western; Bromodeoxyuridine; Catechin; Cell Division; Cells, Cultured; Collagen Type I; Dose-Response Relationship, Drug; Fibronectins; Flow Cytometry; Gene Expression Regulation; Hepatocytes; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Male; Models, Chemical; NF-kappa B; Plasmids; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleases; RNA, Messenger; Tea; Thymidine; Time Factors; Transfection; Transforming Growth Factor beta | 2002 |
Procyanidin B-3, isolated from barley and identified as a hair-growth stimulant, has the potential to counteract inhibitory regulation by TGF-beta1.
Topics: Animals; Biflavonoids; Catechin; Cell Division; Cells, Cultured; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Epidermal Cells; Hair; Hordeum; Mice; Mice, Inbred C3H; Plant Extracts; Proanthocyanidins; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |
Inhibition of BMP-induced ectopic bone formation by an antiangiogenic agent (epigallocatechin 3-gallate).
Topics: Alkaline Phosphatase; Angiogenesis Inhibitors; Animals; Bone and Bones; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Calcium; Cartilage; Catechin; Choristoma; Collagen Type II; Drug Delivery Systems; Humans; Male; Osteogenesis; Rats; Rats, Wistar; Skin Diseases; Transforming Growth Factor beta | 2002 |
Cocoa flavonols and procyanidins promote transforming growth factor-beta1 homeostasis in peripheral blood mononuclear cells.
Topics: Biflavonoids; Cacao; Catechin; Enzyme-Linked Immunosorbent Assay; Flavonoids; Flavonols; Homeostasis; Humans; In Vitro Techniques; Monocytes; Proanthocyanidins; Transforming Growth Factor beta | 2003 |
Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
Topics: Adenocarcinoma; Antineoplastic Agents; Caffeic Acids; Catechin; Cell Movement; Curcumin; Humans; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenylethyl Alcohol; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sulindac; Transforming Growth Factor beta; Tumor Cells, Cultured | 2004 |
Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14.
Topics: Caspase 14; Caspases; Catechin; Cell Differentiation; Cell Line; Cyclin-Dependent Kinase Inhibitor p57; Epidermal Cells; Epidermis; Gene Expression Regulation; Humans; Keratinocytes; Nuclear Proteins; RNA, Messenger; Tea; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
Topics: Catechin; Cell Line, Tumor; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Receptor, IGF Type 1; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta2 | 2005 |
Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits ethanol-induced activation of pancreatic stellate cells.
Topics: Actins; Animals; Antioxidants; Camellia sinensis; Catechin; Cell Membrane; Cells, Cultured; Collagen; Collagen Type I; Ethanol; Flavonoids; Gene Expression; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pancreas; Phenols; Polyphenols; Rats; Rats, Wistar; Superoxide Dismutase; Transforming Growth Factor beta | 2006 |
The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells.
Topics: Animals; Antioxidants; Catechin; Cell Culture Techniques; Cells, Cultured; Connective Tissue Growth Factor; Culture Media; Dose-Response Relationship, Drug; Extracellular Matrix; Fibrinogen; Fibrosis; Glutathione; Hepatocytes; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lipid Peroxidation; Liver; Male; Procollagen; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Transforming Growth Factor beta; Signal Transduction; Tea; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Procyanidin oligomers counteract TGF-beta1- and TGF-beta2-induced apoptosis in hair epithelial cells: an insight into their mechanisms.
Topics: Animals; Apoptosis; Biflavonoids; Catechin; Cells, Cultured; Dose-Response Relationship, Drug; Epithelial Cells; Hair; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Inbred C3H; Proanthocyanidins; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transforming Growth Factor beta2 | 2006 |
Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats.
Topics: Animals; Body Weight; Catechin; Cyclooxygenase 2; Diabetic Nephropathies; Fibronectins; Kidney; Male; NF-kappa B; Nitric Oxide Synthase Type II; Organ Size; Proteinuria; Rats; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transforming Growth Factor beta | 2006 |
(-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Topics: Animals; Animals, Newborn; Antioxidants; Blotting, Western; Catechin; Cell Line; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; JNK Mitogen-Activated Protein Kinases; Mice; Osteoblasts; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Tea; Transforming Growth Factor beta | 2008 |
Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence.
Topics: Animals; Antioxidants; Brucella abortus; Catalase; Catechin; Disease Models, Animal; Fatigue Syndrome, Chronic; Glutathione; Hyperalgesia; Lipid Peroxidation; Lipopolysaccharides; Locomotion; Mice; Mice, Inbred Strains; Nitrites; Oxidative Stress; Superoxide Dismutase; Swimming; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2009 |
Antiproliferative effect of catechin in GRX cells.
Topics: Autophagy; Cacao; Caspase 3; Catechin; Cell Proliferation; Cells, Cultured; Hepatic Stellate Cells; Humans; Interleukin-6; Liver; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2012 |
EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Catechin; Cell Line, Tumor; Down-Regulation; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; MAP Kinase Signaling System; Plant Extracts; Smad2 Protein; Transforming Growth Factor beta | 2012 |
The effects of ErhBMP-2-/EGCG-coated BCP bone substitute on dehiscence around dental implants in dogs.
Topics: Animals; Bone Morphogenetic Protein 2; Bone Substitutes; Catechin; Dental Implants; Dental Prosthesis Design; Dogs; Guided Tissue Regeneration, Periodontal; Hydroxyapatites; Osteogenesis; Recombinant Proteins; Titanium; Transforming Growth Factor beta | 2014 |
Procyanidin C1 from Cinnamomi Cortex inhibits TGF-β-induced epithelial-to-mesenchymal transition in the A549 lung cancer cell line.
Topics: Biflavonoids; Cadherins; Catechin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cinnamomum zeylanicum; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Humans; Lung Neoplasms; Neoplasm Metastasis; Plant Extracts; Proanthocyanidins; Smad2 Protein; Transforming Growth Factor beta | 2013 |
The polyphenols (-)-epigallocatechin-3-gallate and luteolin synergistically inhibit TGF-β-induced myofibroblast phenotypes through RhoA and ERK inhibition.
Topics: Catechin; Cell Line; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Luteolin; Myofibroblasts; Phenotype; rhoA GTP-Binding Protein; Transforming Growth Factor beta | 2014 |
Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Catechin; Choline Deficiency; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Inflammation Mediators; Lipids; Liver; Male; Methionine; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Signal Transduction; Transforming Growth Factor beta | 2015 |
Epigallocatechin Gallate Remodels Fibrils of Lattice Corneal Dystrophy Protein, Facilitating Proteolytic Degradation and Preventing Formation of Membrane-Permeabilizing Species.
Topics: Amyloid; Antioxidants; Catechin; Cell Membrane Permeability; Corneal Dystrophies, Hereditary; Extracellular Matrix Proteins; Humans; Liposomes; Peptide Hydrolases; Protein Domains; Protein Multimerization; Proteolysis; Transforming Growth Factor beta | 2016 |
Impact of EGCG Supplementation on the Progression of Diabetic Nephropathy in Rats: An Insight into Fibrosis and Apoptosis.
Topics: Animals; Apoptosis; Catechin; Diabetic Nephropathies; Fibrosis; Humans; Kidney; Male; Prospective Studies; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2017 |
Green Tea Catechins Effectively Altered Hepatic Fibrogenesis in Rats by Inhibiting ERK and Smad1/2 Phosphorylation.
Topics: Animals; Camellia sinensis; Catechin; Female; Humans; Liver; Liver Cirrhosis; MAP Kinase Signaling System; Phosphorylation; Plant Extracts; Rats; Rats, Sprague-Dawley; Smad1 Protein; Smad2 Protein; Transforming Growth Factor beta | 2019 |
Bioengineered Hybrid Collagen Scaffold Tethered with Silver-Catechin Nanocomposite Modulates Angiogenesis and TGF-β Toward Scarless Healing in Chronic Deep Second Degree Infected Burns.
Topics: Animals; Burns; Catechin; Collagen; Nanocomposites; Rats; Silver; Skin; Transforming Growth Factor beta; Wound Healing | 2020 |
EGCG targeting Notch to attenuate renal fibrosis
Topics: Animals; Antioxidants; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Injections, Intraperitoneal; Mice; Mice, Inbred ICR; Random Allocation; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Streptozocin; Transforming Growth Factor beta | 2020 |
Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
Topics: Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Plant Extracts; Reactive Oxygen Species; Signal Transduction; Smad Proteins; Tea; Transforming Growth Factor beta; Uterine Cervical Neoplasms | 2021 |
Catechin, epicatechin, curcumin, garlic, pomegranate peel and neem extracts of Indian origin showed enhanced anti-inflammatory potential in human primary acute and chronic wound derived fibroblasts by decreasing TGF-β and TNF-α expression.
Topics: Anti-Inflammatory Agents; Antioxidants; Catechin; Curcumin; Fibroblasts; Garlic; Humans; Pomegranate; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2023 |